Skip to main content

Emergent BioSolutions will produce COVID-19 vaccines in Baltimore, Rockville under $628 million federal contract – Baltimore Sun

By June 8, 2020News
Emergent Logo

Emergent Logo

Emergent BioSolutions Inc. will help produce COVID-19 vaccines in Baltimore and Rockville under a federal contract.

Gaithersburg-based Emergent said Tuesday it will manufacture vaccines under an existing contract with a division of U.S. Department of Health & Human Services, assisting government efforts to fast-track the vaccine. Emergent has long worked with the federal health agency’s Biomedical Advanced Research and Development Authority.

 

{iframe}https://www.baltimoresun.com/coronavirus/bs-md-emergent-biosolutions-manufacture-covid-vaccines-20200602-2jaycpufzbd4hpjawc46aso5hm-story.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.